Literature DB >> 3292250

Development of the nervous and cardiovascular systems in low-birth-weight infants fed a taurine-supplemented formula.

D V Michalk1, R Ringeisen, F Tittor, H Lauffer, K H Deeg, H J Böhles.   

Abstract

An adapted cow's milk formula with or without supplemental taurine (480 mumol/l) was fed for 16 weeks to 20 low-birth-weight infants. In the 2nd and 16th weeks of life, respectively, the following parameters were determined: growth, sonography of heart and brain, ECG, EEG, neurological development and the taurine concentration of plasma and urine. None of the parameters investigated was influenced by taurine supplementation except the urinary taurine excretion. At least according to these data, the addition of taurine to whey-predominant infant formulae seems to be unnecessary for the development of heart and brain function in low-birth-weight infants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292250     DOI: 10.1007/bf00442699

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Feeding the low-birth-weight infant: II. Effects of taurine and cholesterol supplementation on amino acids and cholesterol.

Authors:  D K Rassin; G E Gaull; A L Järvenpää; N C Räihä
Journal:  Pediatrics       Date:  1983-02       Impact factor: 7.124

2.  Milk protein quantity and quality in low-birth-weight infants. III. Effects on sulfur amino acids in plasma and urine.

Authors:  G E Gaull; D K Rassin; N C Räihä; K Heinonen
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

3.  Role of taurine in feeding the low-birth-weight infant.

Authors:  E Okamoto; D K Rassin; C L Zucker; G S Salen; W C Heird
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

4.  Milk protein quantity and quality in the term infant. II. Effects on acidic and neutral amino acids.

Authors:  A L Järvenpää; D K Rassin; N C Räihä; G E Gaull
Journal:  Pediatrics       Date:  1982-08       Impact factor: 7.124

5.  New evidence for taurine biosynthesis in man obtained from 18O2 inhalation studies.

Authors:  C S Irving; L Marks; P D Klein; N Foster; P L Gadde; T N Chase; D Samuel
Journal:  Life Sci       Date:  1986-02-10       Impact factor: 5.037

6.  Fat absorption in preterm infants fed a taurine-enriched formula.

Authors:  C M Bijleveld; R J Vonk; A Okken; J Fernandes
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

7.  Physiological and experimental regulation of taurine content in the heart.

Authors:  R J Huxtable; J Chubb; J Azari
Journal:  Fed Proc       Date:  1980-07

8.  Retinal degeneration in primates raised on a synthetic human infant formula.

Authors:  J A Sturman; G Y Wen; H M Wisniewski; M D Neuringer
Journal:  Int J Dev Neurosci       Date:  1984       Impact factor: 2.457

9.  Determinations of taurine in milk and infant formula diets.

Authors:  H F Erbersdobler; E Trautwein; H G Greulich
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

10.  Nutritional requirement for taurine in patients receiving long-term parenteral nutrition.

Authors:  H S Geggel; M E Ament; J R Heckenlively; D A Martin; J D Kopple
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  3 in total

1.  Effects of Taurine Supplementation on Growth in Low Birth Weight Infants: A Systematic Review and Meta-Analysis.

Authors:  Shun-Li Cao; Hong Jiang; Shi-Ping Niu; Xiao-Hu Wang; Shan Du
Journal:  Indian J Pediatr       Date:  2018-01-25       Impact factor: 1.967

2.  Taurine indirectly increases [Ca]i by inducing Ca2+ influx through the Na(+)-Ca2+ exchanger.

Authors:  G Bkaily; D Jaalouk; S Sader; H Shbaklo; P Pothier; D Jacques; P D'Orléans-Juste; E J Cragoe; R Bose
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 3.  Effect of taurine supplementation on growth and development in preterm or low birth weight infants.

Authors:  A Verner; S Craig; W McGuire
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.